2020, Número 5
<< Anterior Siguiente >>
salud publica mex 2020; 62 (5)
La salud pública en la primera ola: una agenda para la cooperación ante Covid-19
Barrientos-Gutiérrez T, Alpuche-Aranda C, Lazcano-Ponce E, Pérez-Ferrer C, Rivera-Dommarco J
Idioma: Español
Referencias bibliográficas: 58
Paginas: 598-606
Archivo PDF: 269.40 Kb.
RESUMEN
El Covid-19 representa uno de los retos más grandes en la
historia reciente de la salud pública. Es fundamental que se
fortalezcan los lazos de cooperación científica bajo un objetivo
común: proteger la salud de la población. En este artículo
se presentan ideas que necesitan un desarrollo urgente y
colaborativo. Se discute la estimación de la magnitud de la
epidemia mediante un panel nacional de seroprevalencia y
nuevas estrategias para mejorar el monitoreo en tiempo real
de la epidemia. También se analizan las externalidades negativas
asociadas con la respuesta a la pandemia. Finalmente,
se presenta un marco general para el desarrollo de ideas
para salir del confinamiento, resaltando la importancia de
implementar acciones estructurales, sostenibles y equitativas.
Se hace un llamado a la solidaridad y la cooperación, donde
nuestros esfuerzos y creatividad se dediquen a la resolución
de los problemas que enfrentan México y el mundo.
REFERENCIAS (EN ESTE ARTÍCULO)
World Health Organization. Surveillance strategies for COVID-19 human infection. Interim guidance. No. WHO/2019-nCoV/National_ Surveillance/2020. Ginebra: WHO, 2020 [citado mayo 19, 2020]. Disponible en: https://www.who.int/publications-detail/surveillancestrategies- for-covid-19-human-infection
Pan American Health Organization. Operational Guidelines for Sentinel Severe Acute Respiratory Infection (SARI) Surveillance. Washington: OPS, 2014.
Lipsitch M, Donnelly CA, Fraser C, Blake IM, Cori A, Dorigatti I, et al. Potential biases in estimating absolute and relative case-fatality risks during outbreaks. PLoS Negl Trop Dis. 2015;9(7):1-16. https://doi.org/10.1371/ journal.pntd.0003846
Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, Switzerland. medRxiv. 2020. https://doi.org/10.1101/2020.05.02.20088898
Gobierno de España. Estudio ENE-COVID19: primera ronda estudio nacional de sero-epidemiología de la infección por SARS-COV-2 en España. Madrid: Gobierno de España, 2020 [citado mayo 19, 2020]. Disponible en: https://www.ciencia.gob.es/stfls/MICINN/Ministerio/FICHEROS/ENECOVID_ Informe_preliminar_cierre_primera_ronda_13Mayo2020.pdf
World Health Organization. Coronavirus disease (COVID-19) technical guidance: Unity Studies: Early Investigation Protocols. Ginebra: WHO, 2020 [citado mayo 15, 2020]. Disponible en: https://www.who.int/emergencies/ diseases/novel-coronavirus-2019/technical-guidance/early-investigations
Subramanian SV, James KS. Use of the Demographic and Health Survey framework as a population surveillance strategy for COVID-19. Lancet Glob Heal. 2020. https://doi.org/10.1016/S2214-109X(20)30213-8
Méndez-Herrera A, Arias-Toledo E, Sánchez-Alemán M, Olamendi- Portugal ML, Ruiz-Gómez J, Díaz-Ortega JL. Prevalencia de anticuerpos frente a parotiditis en niños y adolescentes a dos años de haberse introducido la vacuna SRP. Salud Publica Mex. 2018;60(1):71-76. https:// doi.org/10.21149/8138
Gobierno de España. Propuesta de diseño para llevar a cabo la encuesta sero-epidemiológica de la infección por SARS-COV-2 en España. Madrid: Gobierno de España, 2020 [citado mayo 15, 2020]. Disponible en: http:// cadenaser00.epimg.net/descargables/2020/04/06/9e8cf1112ff914621956e 1b519130636.pdf
Kahn R, Kennedy-Shaffer L, Grad Y, Robins JM, Lipsitch M. Potential biases arising from epidemic dynamics in observational seroprotection studies. medRxiv. 2020. https://doi.org/10.1101/2020.05.02.20088765
Medema G, Heijnen L, Elsinga G, Italiaander R, Brouwer A. Presence of SARS-Coronavirus-2 in sewage. medRxiv. 2020. https://doi. org/10.1101/2020.03.29.20045880
World Health Organization. Coronavirus disease (COVID-19) technical guidance: Surveillance and case definitions. Ginebra: WHO, 2020 [citado mayo 15, 2020]. Disponible en: https://www.who.int/emergencies/ diseases/novel-coronavirus-2019/technical-guidance/surveillance-and-casedefinitions
World Health Organization. Contact tracing in the context of COVID-19. Ginebra: WHO, 2020 [citado mayo 15, 2020]. Disponible en: https://www.who.int/publications-detail/contact-tracing-in-the-context-ofcovid- 19
Allen D, Block S, Gostin L. Roadmap to Pandemic Resilience. Cambridge MA: Harvard University, 2020 [citado mayo 15, 2020]. Disponible en: https://ethics.harvard.edu/files/center-for-ethics/files/roadmaptopandemicresilience_ updated_4.20.20.pdf
Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA. 2020. https://doi.org/10.1001/jama.2020.8259
Watson J, Whiting-Penny F BJE. Interpreting a covid-19 test result BMJ 2020. BMJ. 2020. https://doi.org/10.1136/bmj.m1808
Gostic KM, Gomez ACR, Mummah RO, Kucharski AJ, Lloyd-Smith JO. Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19. Elife. 2020;9:e55570. https://doi.org/10.7554/ eLife.55570
Kucirka LM, Lauer SA, Laeyendecker O, Boon D. Variation in falsenegative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med. 2020. https:// doi.org/10.7326/M20-1495
Tahamtan A, Ardebili A. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev Mol Diagn. 2020:20(5):453-4. https:// doi.org/10.1080/14737159.2020.1757437
Weinberg CR. Making the Best Use of Test Kits for COVID-19. Am J Epidemiol. 2020. https://doi.org/10.1093/aje/kwaa080
Peto J, Alwan NA, Godfrey KM, Burguess RA, Hunter DJ, Rioli E, Romer P. Universal weekly testing as the UK COVID-19 lockdown exit strategy. Lancet. 2020;395(10234);1420-1. https://doi.org/10.1016/S0140- 6736(20)30936-3
Lou B, Li T, Zheng S, Su Y, Li Z, Liu W, et al. Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset. medRxiv. 2020. https://doi.org/10.1101/2020.03.23.20041707
Altmann DM, Douek DC, Boyton RJ. What policy makers need to know about COVID-19 protective immunity. Lancet. 2020;6736(20):19-21. https://doi.org/10.1016/S0140-6736(20)30985-5
Persad G, Emanuel EJ. The ethics of COVID-19 immunity-based licenses (“immunity passports”). JAMA. 2020. https://doi.org/10.1001/ jama.2020.8102
Hall MA, Studdert DM. Privileges and immunity certification during the COVID-19 pandemic. JAMA. 2020. https://doi.org/10.1001/jama.2020.7712
Bilal U, Barber S, Diez-Roux AV. Early evidence of disparities in COVID-19 Testing in US Cities. medRxiv. 2020. https://doi. org/10.1101/2020.05.01.20087833
World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Ginebra: WHO, 2020 [citado mayo 15, 2020]. Disponible en: https://www.who.int/docs/default-source/ coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
European Centre for Disease Prevention and Control (ECDC). Contact Tracing for COVID-19: Current Evidence, Options for Scale-up and an Assessment of Resources Needed. Suecia: ECDC, 2020 [citado mayo 15, 2020]. Disponible en: https://www.ecdc.europa.eu/sites/default/files/documents/ COVID-19-Contract-tracing-scale-up.pdf
Li J, Guo X. COVID-19 contact-tracing apps: a survey on the global deployment and challenges. arXiv. 2020;1. Nueva York: Cornell University, 2020 [citado mayo 15, 2020]. Disponible en: http://arxiv.org/ abs/2005.03599
Gorji H, Arnoldini M, Jenny DF, Hardt W-D, Jenny P. STeCC: smart testing with contact counting enhances Covid-19 mitigation by bluetooth 2 app based contact tracing. medRxiv. 2020. https://doi. org/10.1101/2020.03.27.20045237
Instituto Nacional de Estadística y Geografía. Aviso COVID-19. México: INEGI, 2020 [citado mayo 18, 2020]. Disponible en: https://www.inegi.org. mx/default.html
Legay A, Gala JL. Open Source Against COVID-19. Contact Tracing Apps. Leuven: Zenjoy, 2020 [citado mayo 15, 2020]. Disponible en: https:// www.opensourceagainstcovid19.org/es/
Douglas M, Katikireddi SV, Taulbut M, McKee M, McCartney G. Mitigating the wider health effects of covid-19 pandemic response. BMJ. 2020;369:m1557. https://doi.org/10.1136/bmj.m1557
Lai AG, Pasea L, Banerjee A, Denaxas S, Katsoulis M, Chang WH, et al. Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. medRxiv. 2020. https://doi. org/10.1101/2020.05.27.20083287
Gopalakrishnan A, Mossaid A, Lo KB, Vasudevan V, McCullough PA, Rangaswami J. Fulminant acute kidney injury in a young patient with novel coronavirus 2019. Cardiorenal Med. 2020:1-6. https://doi. org/10.1159/000508179
Casini A, Fontana P, Glauser F, Robert-Ebadi H, Righini M, Blondon M. Risque thrombotique veineux induit par le SARS-CoV-2 : prévalence, recommandations et perspectives. Rev Med Suisse. 2020;16(692):951-4.
Felix-Cardoso J, Vasconcelos H, Rodrigues P, Cruz-Correia R. Excess mortality during COVID-19 in five European countries and a critique of mortality analysis data. medRxiv. 2020. https://doi. org/10.1101/2020.04.28.20083147
Faust J, del Rio C. Relative disease burdens of COVID-19 and seasonal influenza in New York City, February 1- April 18, 2020. medRxiv. 2020. https://doi.org/10.1101/2020.04.22.20073551
Faust JS, del Rio C. The metric that could tell us when it’s safe to reemerge. The Washington Post, mayo 4, 2020 [citado mayo 15, 2020]. Disponible en: https://www.washingtonpost.com/opinions/2020/05/04/ metric-that-could-tell-us-when-its-safe-reemerge/
Li J. Rehabilitation management of patients with COVID-19. Lessons learned from the first experiences in China. Eur J Phys Rehabil Med. 2020. https://doi.org/10.23736/S1973-9087.20.06292-9
Lew HL, Oh-Park M, Cifu DX. The war on COVID-19 pandemic: role of rehabilitation professionals and hospitals. Am J Phys Med Rehabil. 2020. https://doi.org/10.1097/PHM.0000000000001460
Wong LE, Hawkins JE, Langness S, Murrell KL, Iris P. Where are all the patients? Addresing Covid-19 fear to encourage sick patients to seek emergency care. Catalyst. 2020 [citado mayo 16, 2020]. Disponible en: https://catalyst.nejm.org/doi/full/10.1056/CAT.20.0193?query=C19#. Xr_1dBLpU44.twitter
Omboni S. Telemedicine during the COVID-19 in Italy: a missed opportunity? Telemed e-Health. 2020. https://doi.org/10.1089/tmj.2020.0106
Santoli JM, Lindley MC, DeSilva MB, Kharbanda EO, Daley MF, Galloway L, et al. Effects of the COVID-19 pandemic on routine pediatric vaccine ordering and administration — United States, 2020. MMWR. 2020;69(19):591-3. https://doi.org/10.15585/mmwr.mm6919e2
Mongua-Rodríguez N, Hubert C, Ferreira-Guerrero E, de Castro F, Ferreyra-Reyes L, Villalobos-Hernández A, et al. Tendencias en las coberturas de vacunación en niños de 12 a 23 y 24 a 35 meses en México. Salud Publica Mex. 2019;61(6):809-920. https://doi.org/10.21149/10559
Orcutt M, Patel P, Burns R, Hiam L, Aldridge R, Devakumar D, et al. Global call to action for inclusion of migrants and refugees in the COVID-19 response. Lancet. 2020. https://doi.org/10.1016/S0140- 6736(20)30971-5
Platt L, Elmes J, Stevenson L, Holt V, Rolles S, Stuart R. Sex workers must not be forgotten in the COVID-19 response. Lancet. 2020. https:// doi.org/10.1016/S0140-6736(20)31033-3
Bradbury-Jones C, Isham L. The pandemic paradox: The consequences of COVID-19 on domestic violence. J Clin Nurs. 2020. https://doi. org/10.1111/jocn.15296
Volkow ND. Collision of the COVID-19 and Addiction Epidemics. Ann Intern Med. 2020. https://doi.org/10.7326/m20-1212
Xie X, Xue Q, Zhou Y, Zhu K, Liu Q, Zhang J, et al. Mental health status among children in home confinement during the coronavirus disease 2019 outbreak in Hubei Province, China. JAMA Pediatr. 2020. https://doi. org/10.1001/jamapediatrics.2020.1619
Ammar A, Trabelsi K, Brach M, Chtourou H, Boukhris O, Masmoud L, et al. Effects of home confinement on mental health and lifestyle behaviours during the COVID-19 outbreak: Insight from the “ECLB-COVID19” multi countries survey. medRxiv. 2020. https://doi. org/10.1101/2020.05.04.20091017
Ammar A, Brach M, Trabelsi K, Boukhris O, Masmoudi L, Bouaziz B, et al. Effects of COVID-19 home confinement on physical activity and eating behaviour preliminary results of the ECLB-COVID19 international onlinesurvey. medRxiv. 2020. https://doi.org/10.1101/2020.05.04.20072447
Roberton T, Carter ED, Chou VB, Stegmuller AR, Jackson BD, Tam Y, et al. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. Lancet Glob Heal. 2020. https://doi.org/10.1016/S2214- 109X(20)30229-1
Naja F, Hamadeh R. Nutrition amid the COVID-19 pandemic: a multilevel framework for action. Eur J Clin Nutr. 2020. https://doi.org/10.1038/ s41430-020-0634-3
Frieden TR. A framework for public health action: The health impact pyramid. Am J Public Health. 2010;100(4):590-5. https://doi.org/10.2105/ AJPH.2009.185652
Backholer K, Beauchamp A, Ball K, Turrell G, Martin J, Woods J, et al. A framework for evaluating the impact of obesity prevention strategies on socioeconomic inequalities in weight. Am J Public Health. 2014;104(10):e43-e50. https://doi.org/10.2105/AJPH.2014.302066
Arias J. Coronavirus (Covid-19): con Ciclovía se descongestionará TransMilenio. Bogota.gov.co [citado mayo 16, 2020]. Disponible en: https:// bogota.gov.co/mi-ciudad/coronavirus-covid-19-con-ciclovia-se-descongestionara- transmilenio
Karin O, Bar-On YM, Milo T, Katzir I, Mayo A, Korem Y, et al. Adaptive cyclic exit strategies from lockdown to suppress COVID- 19 and allow economic activity. medRxiv. 2020. https://doi. org/10.1101/2020.04.04.20053579